Role of hepatocyte growth factor in endothelial regulation: prevention of high D-glucose-induced endothelial cell death by prostaglandins and phosphodiesterase type 3 inhibitor

Ryuichi Morishita(The University of Osaka), Toshio Ogihara(Osaka University), Motokuni Aoki(Osaka City University), Shinpei Hayashi(The University of Osaka), Takashi Nakamura(Tohoku University), Hidetsugu Matsushita, Y. Yo(The University of Osaka), A Moriguchi(The University of Osaka), S. Nakamura(The University of Osaka), Jitsuo Higaki(Saiseikai Matsuyama Hospital), Kunio Matsumoto(Kanazawa University)
Diabetologia
August 19, 1997
10.1007/s001250050787
Cited by 82

Related Papers

Erratum: The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009)
|Hypertension Research|2014|1.4k
Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis
|The Lancet|2021|997
Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations
|Cancer Research|2008|642
In vivo transfection of cis element “decoy” against nuclear factor- κB binding site prevents myocardial infarction
|Nature Medicine|1997|589
Hepatocyte growth factor gene therapy of liver cirrhosis in rats
|Nature Medicine|1999|588